Señales en vivo de ITOS | Maximiza tus Ganancias con Getagraph.com

VENDER 106923 min ago

@ $10.28

Emitido: 14 feb 2024 @ 09:30

Retorno: 5.06%

Señal anterior: feb 12 - 15:25

Señal anterior: Comprar

Retorno: -3.95 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients...

Stats
Volumen de hoy	135 657
Volumen promedio	277 176
Capitalización de mercado	387.11M
EPS	$0 ( 2024-03-20 )
Próxima fecha de ganancias	( $-1.020 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.43
ATR14	$0.0140 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-07	Gall Matthew	Buy	163 200	Stock Option (Right to Buy)
2024-03-07	Call Matthew	Buy	225 000	Stock Option (Right to Buy)
2024-03-07	Mcgrath Yvonne	Buy	153 600	Stock Option (Right to Buy)
2024-03-07	Detheux Michel	Buy	590 400	Stock Option (Right to Buy)
2024-03-07	Desimone Jill	Buy	44 766	Stock Option (Right to Buy)

INSIDER POWER
64.32
Last 98 transactions
Buy: 4 056 310 \| Sell: 3 240 538

Volumen Correlación

Largo: -0.05 (neutral)

Corto: 0.71 (moderate)

Signal:(45.154) Neutral

iTeos Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas
VERU	0.964
AADI	0.945
MDRX	0.944
TWST	0.941
SGMO	0.941
LSBK	0.939
BLNK	0.936
ACRS	0.936
AKTX	0.936
ALHC	0.936

10 Correlaciones Más Negativas
CPTA	-0.934
RAM	-0.928
SGEN	-0.924
TYHT	-0.916
GPACU	-0.906
DRNA	-0.902
PESI	-0.897
XPON	-0.891
AMPH	-0.886
MLAI	-0.886

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

iTeos Therapeutics, Inc. Correlación - Moneda/Commodity

-0.45
( neutral )

-0.32
( neutral )

0.00
( neutral )

-0.54
( weak negative )

0.00
( neutral )

0.34
( neutral )

iTeos Therapeutics, Inc. Finanzas

Annual	2023
Ingresos:	$12.60M
Beneficio Bruto:	$11.70M (92.87 %)
EPS:	$-3.15

FY	2023
Ingresos:	$12.60M
Beneficio Bruto:	$11.70M (92.87 %)
EPS:	$-3.15

FY	2022
Ingresos:	$267.63M
Beneficio Bruto:	$266.82M (99.70 %)
EPS:	$2.72

FY	2021
Ingresos:	$344 775
Beneficio Bruto:	$344 775 (100.00 %)
EPS:	$0.00881

Financial Reports:

No articles found.

iTeos Therapeutics, Inc.

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.